Case Study:
From Machine-Made to Market-Ready: Reimagining a Multi-Omics Guide
Note: this was a collaboration with Biofluent Communications: Biofluent Communications. Biofluent Communications handled business development and scoping; Chris and Quill Science handled strategy and execution.
The Challenge
A global life sciences company set out to create a “Guide to Multi-Omics” as a sales and educational tool. The first draft, however, had been generated largely by AI. The result was as you might expect: technically accurate in places, but lacking narrative cohesion, depth, and strategic direction.
The content lacked a clear narrative, offered few tangible takeaways, and failed to build a compelling case for multi-omics. With limited guidance and a tight deadline, we stepped in to elevate the material into something credible and sales-ready.
Our Approach
Rather than patching over surface issues, we rebuilt the chapter around the client’s strategic objectives:
Sharper framing. Instead of a textbook-style definition of DNA and genomics, we set genomics in the broader context of multi-omics workflows, including epigenomics and metagenomics, so the chapter naturally led into metabolomics — the company’s commercial focus.
Practical context. Where the AI draft presented sequencing technologies as a dry list, Rather than dryly listing modern sequencing technologies, we explained how and why each is used, highlighting strengths, limitations, and cost/accuracy tradeoffs. This gave the content more relevance for researchers making real experimental choices.
Depth without overload. The AI-generated text included sprawling technology inventories (e.g., CRISPR, bioinformatics, microarrays) that distracted from the sales narrative. We streamlined to the most strategically relevant methods — Sanger, NGS, third-gen sequencing, and single-cell multi-omics — while showing how each connects to experimental considerations.
More relevant case studies. We reworked example case studies into sales-enabling narratives, tying genomic findings directly to disease risk, therapeutic vulnerabilities, and multi-omics integration.
Voice and credibility. We shifted from generic “Genomics is important because…” phrasing to authoritative, reference-backed explanations with clear citations, aligning the tone with scientific rigor and commercial authority.
The result was not just a cleaner chapter, but a model for the entire eBook: structured, credible, and strategically aligned with the client’s sales goals.
Results
The first rewritten chapter landed so well with the client that it immediately reset the standard for the entire project. What was intended as a one-off repair became the blueprint for the full eBook. The client asked us to revise two additional chapters to match the voice, structure, and authority we had established.
In the end, the company gained more than a polished eBook. They gained a trusted strategic partner who could create authoritative and accurate content to support sales conversations and position them as thought leaders in their field.